Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001
High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients Source: Eur Respir J 2006; 28: Suppl. 50, 61s Year: 2006
Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment Source: Eur Respir J 2007; 30: Suppl. 51, 201s Year: 2007
Serum procalcitonin level: clinical significance Source: Eur Respir J 2011; 37: 723 Year: 2011
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017
Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Plasma D-dimer level and stage of primary lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003
High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009